In this CE activity, experts in the field evaluate therapeutic regimens for the management of nAMD and DME that can extend the interval between treatments and offer enhanced durability, efficacy, and safety. Challenging real-world cases are also presented, allowing for application of the educational content into clinical practice.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/retinacme/age-related-macular-degeneration/20240611/namd-and-dme-management-exploring-innovative-alternatives-to-minimize-injection-frequency/overview
- Start Date: 2024-06-11 05:00:00
- End Date: 2024-06-11 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 41907.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest